Development and validation of an [ 18 F]FDG-PET/CT radiomic model for predicting progression-free survival for patients with stage II - III thoracic esophageal squamous cell carcinoma who are treated with definitive chemoradiotherapy.
Noriyoshi TakahashiShohei TanakaRei UmezawaKentaro TakanamiKazuya TakedaTakaya YamamotoYu SuzukiYoshiyuki KatsutaNoriyuki KadoyaKeiichi JinguPublished in: Acta oncologica (Stockholm, Sweden) (2023)
F]FDG-PET/CT radiomic model could predict PFS for patients with esophageal cancer who received dCRT.